Skip to main content

Potassium Acetate Injection

Last Updated: January 6, 2023
Status: Current

Products Affected - Description
    • Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 20 mL vial, 25 count, NDC 51754-2001-04
    • Potassium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-8183-01
Reason for the Shortage
    • Exela has potassium acetate injection on shortage due to increased demand.
    • Pfizer has potassium acetate injection on shortage due to increased demand.
Available Products
    • Potassium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3924-51

Estimated Resupply Dates

    • Exela has potassium acetate 2 mEq/mL 20 mL vials on back order and the company cannot estimate a release date.
    • Pfizer has potassium acetate 2 mEq/mL 20 mL vials on back order and the company estimates a release date of January 2023.

Updated

Updated January 6, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.